Abstract
Zinc is an essential trace metal that has integral roles in numerous biological processes, including enzymatic function, protein structure, and cell signaling pathways. Both excess and deficiency of zinc can lead to detrimental effects on development and metabolism, resulting in abnormalities and disease. We altered the zinc balance within Caenorhabditis elegans to examine how changes in zinc burden affect longevity and healthspan in an invertebrate animal model. We found that increasing zinc levels in vivo with excess dietary zinc supplementation decreased the mean and maximum lifespan, whereas reducing zinc levels in vivo with a zinc-selective chelator increased the mean and maximum lifespan in C. elegans. We determined that the lifespan shortening effects of excess zinc required expression of DAF-16, HSF-1 and SKN-1 proteins, whereas the lifespan lengthening effects of the reduced zinc may be partially dependent upon this set of proteins. Furthermore, reducing zinc levels led to greater nuclear localization of DAF-16 and enhanced dauer formation compared to controls, suggesting that the lifespan effects of zinc are mediated in part by the insulin/IGF-1 pathway. Additionally, zinc status correlated with several markers of healthspan in worms, including proteostasis, locomotion and thermotolerance, with reduced zinc levels always associated with improvements in function. Taken together, these data support a role for zinc in regulating both development and lifespan in C. elegans, and that suggest that regulation of zinc homeostasis in the worm may be an example of antagonistic pleiotropy.
Introduction
Zinc is an essential micronutrient involved in the structure, regulation, and activity for thousands of proteins, and participates in many biological processes such as redox regulation and signal transduction [1–6]. Zinc-dependent functions are widespread within the multicellular organism but especially in the central nervous system, immune system, skeletal and reproductive system [7–13]. Consequently, severe zinc deficiency in humans leads to functional defects in growth and development, hypogonadism, dermatitis, delayed wound healing, and decreased immune function [7–9,11–19]. Conversely, exposure to elevated zinc can also have toxic effects [20,21], which may be in part due to the competitive displacement of other trace metals from their binding sites or adventitious binding to protein regions not normally involved with metal, both leading to protein dysfunction [20–24]. Excess zinc can also promote non-physiological protein aggregation. Hence, maintaining optimal zinc balance is vital for proper physiological functions. Animals prevent zinc deficiency or toxicity through a range of regulatory mechanisms, including altering expression of zinc transporters in response to changing levels of zinc [25–27], chelation of zinc by small molecules such as glutathione or proteins such as metallothionein [21,23,25–28], and sequestration of zinc within intracellular organelles [29–31]. Multiple studies have shown that zinc homeostasis can be efficiently regulated by these mechanisms, even in the face of wide ranges of dietary or environmental zinc exposure [23–31].
Like all animals, the free-living nematode Caenorhabditis elegans requires zinc for survival, and the homeostasis of zinc has been well studied in C. elegans [32–35]. Zinc metabolism in the worm has been shown to be regulated by the highly conserved cation diffusion facilitators (CDF) transporter, Zrt and Irt-like proteins (ZIP) transporter, and metallothionein (MT) protein families [32,33,36–40]. CDF-1, CDF-2 and SUR-7 are the known members of CDF family transporters [32,36–38]. These transporters are thought to sequester or move zinc throughout the body. The expression of zinc transporters is increased at high level of zinc exposure, suggesting they can also move zinc back into the gut and out of the animal [39]. Worms with loss of function mutations of these zinc transporters show growth defects and abnormal zinc content compared to wildtype animals [34,39]. Furthermore, CDF transporter mutants display heightened toxicity towards increasing concentration of zinc [39]. The CDF-1 transporter is similar to vertebrate ZnT-1, with the highest localization in intestinal cells [36–38]. The CDF-2 transporter is similar to vertebrate ZnT-2, which is more abundant in vesicles [36,38], suggesting an important role in zinc storage. The SUR-7 transporter, predominantly expressed in the endoplasmic reticulum, may function to sequester zinc ions in cellular organelle [38]. Further analysis of CDF-1 and CDF-2 suggests that these transporters have antagonistic functions in mediating zinc content in vivo [38]. The MT protein family comprises several small molecular weight, thiol-rich proteins shown to sequester zinc and other metals in vivo. Deletion of MT proteins result in increased Zn accumulation and increased sensitivity to high zinc levels [33]. Despite a detailed knowledge of zinc regulatory proteins, only a few studies have examined the effects of imbalances in zinc levels upon the development, metabolism, and aging of worms [32–35].
In this paper, we further characterized the effect of zinc status on C. elegans lifespan and healthspan. C. elegans have well-established culture conditions that permit manipulation of dietary zinc [34,36,39,41]. We found zinc supplementation cause a decrease in lifespan, which required DAF-16, HSF-1, SKN-1. In contrast, reductions in zinc levels resulted in an increased lifespan, which was in part dependent on DAF-16, HSF-1, SKN-1. Furthermore, we also examined the effect of alteration in zinc burden on key processes in development and aging, such as dauer formation and protein aggregation. Zinc balance appears to be critical for worm development, and it may limit lifespan through antagonistic pleiotropic mechanisms involving multiple longevity pathways.
Results
Zinc availability alters C. elegans lifespan
To characterize the effects of zinc on lifespan, wildtype C. elegans populations were cultured on noble agar minimal media (NAMM) containing ZnSO4 added to the E. coli OP50 bacteria. We first tested for toxicity of the supplemental zinc by monitoring growth and body size development of the worms. Worms cultured with zinc supplemented up to 500μM demonstrated similar growth and body size compared to wildtype populations (S1 Fig). Compared to wildtype populations (1.03±0.16 mm), worms treated with 200μM zinc were on average 0.93±0.23 mm, 500μM zinc were 0.99±0.27 mm, and 1mM zinc were 0.82±0.17 mm long. Higher concentrations of up to 5mM zinc showed significant reductions in growth and body size, and obvious increases in population death (data not shown). Therefore, we used 500μM as the maximum zinc dose for all future experiments.
Lifespan analysis was performed under conditions of chronic exposure to supplemental zinc. The mean life span of control wildtype worms was 16.1±0.9 days. When worms were cultured with 500μM zinc starting at the L3 development stage, the populations showed a reduced survival time of 14.3±0.4 days, representing a 14% decrease in mean lifespan (Fig 1A). The effect of zinc on population lifespan were dose dependent (S2 Fig). However, when the exposure to excess zinc was delayed until day 5 of adulthood, the worms did not show a change in lifespan (controls 14.9±0.9 days vs. zinc treated 15.4±0.7 days), suggesting that the effect of excess zinc on lifespan only occur when exposed during early development (Fig 1B). To demonstrate the lifespan effect was due to zinc and not due to the sulfate anion, testing was repeated with 500μM ZnCl2, which yielded comparable results to ZnSO4 treatment (S3 Fig).
We tested whether providing supplemental zinc through diet increased the total zinc levels within the worms using inductively-coupled plasma optical emission spectrometry (ICP-OES) [42]. Baseline zinc content was determined to be 0.09 ± 0.02 μg/mg for the L3 stage, 0.10 ± 0.02 μg/mg for 1-day old adult, and 0.14±0.03 μg/mg for 5-day old adults, so only a moderate basal increase in zinc content with age. We found that worms supplemented with 500μM zinc had a 109.0±8.9% increase in total zinc content compared to control worms (Fig 1C), but no significant change in other metal content (data not shown). To verify the specificity of the zinc effect, we used MgSO4 instead of zinc as an additional control, as the magnesium ion has a similar charge and ionic radius compared to zinc but does not bind to the FluoZin-3 probe [43]. MgSO4 supplementation did not increase FluorZin-3 fluorescence in the worms or alter the response to TPEN (Fig 2A). Additionally, it was possible that the excess zinc affected bacterial viability, causing the release of bacterial metabolites that could influence C. elegans lifespan. To test whether the zinc-dependent decrease in lifespan resulted in part from dead bacteria, lifespan assays were repeated using UV-killed OP50 E. coli for feeding. The mean lifespan of control worms was 18.6± 0.7 days compared to 16.3±0.7 days for worms cultured on supplemental zinc (12% decrease), which was similar to results from supplemental zinc with living bacteria, suggesting that altered bacterial metabolites did not explain the shortened lifespan in worms (S3 Fig).
In addition to direct supplementation of diet, we tested another method to increase zinc by feeding worms E. coli that were genetically mutated in the gene zitB, a zinc transporter in the bacterial cytoplasmic membrane. ZitB mutants cannot efficiently efflux excess zinc from within the cell, and thus have higher levels of endogenous zinc [44]. When wildtype worms were fed ZitB bacteria, mean lifespan decreased (S4 Fig), similar to worms fed wildtype bacteria plus dietary zinc supplementation. Total zinc content within the worms also increased after the worms were fed ZitB bacteria (S4 Fig), similar to control worms fed with dietary zinc supplementation. These results support a conclusion that an elevated zinc burden results in a significantly decreased lifespan in wildtype worms.
Since increasing zinc burden in worms led to a shortened lifespan, we reasoned that reducing zinc levels might have a beneficial effect. To do this, we used N, N, N′, N′-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN), a membrane-permeable zinc-selective chelator that binds zinc with high affinity [32]. Previous reports have successfully used TPEN in worms up to 200μM [32], but we also tested for toxicity in our system by monitoring growth and body size development of the worms. We observed that worms cultured with TPEN up to 200μM demonstrated similar growth and body size compared to wildtype populations (S5 Fig). Compared to wildtype populations (1.07±0.12 mm), worms treated with 50μM TPEN were 1.03±0.18 mm, 100μM TPEN were 0.94±0.21 mm, and 200μM zinc were 0.85±0.28 mm long. Higher concentrations of up to 400μM TPEN showed significant reductions in growth and body size, and obvious increases in population death (data not shown).
Lifespan analysis was then performed under conditions of chronic exposure to TPEN. The mean life span of TPEN-treated worms (23.1±0.7 days) was significantly greater than control worms (16.1±0.9 days), representing a 43% increase in mean lifespan (Fig 1A). The effect of TPEN on population lifespan was dose dependent (S2 Fig). However, when exposure to TPEN was delayed until day 5 of adulthood, the worms did not show a change in lifespan, suggesting that reducing zinc has a positive effect on lifespan during early adulthood (Fig 1B). We then attempted to saturate the chelating effects of TPEN by adding additional dietary zinc (500μM). When animals were cultured with zinc (500μM) and TPEN (200μM) together, the beneficial effect of TPEN was blocked (Fig 2B). Collectively, these data show that increasing zinc levels in vivo by dietary supplementation decreased population lifespan, whereas decreasing zinc levels in vivo increased lifespan in C. elegans.
We then treated synchronous populations of worms with 200μM TPEN in NAMM media plates, seeded with OP50 bacteria for 72 hours and then harvested for ICP-OES analysis. The treated worms had a 36% decrease in zinc level (Fig 1C), but no significant change in other metal content (data not shown). We then examined the changes in zinc level in vivo using the FluoZin-3 zinc-selective fluorescent probe. FluoZin-3 fluorescence decreased by over 30% after treatment with TPEN (Fig 1D). Additionally, TPEN treatment effects on FluoZin-3 fluorescence were attenuated by co-treatment of zinc (Fig 2A). To verify the specificity for zinc, we substituted magnesium instead of zinc, but magnesium did not attenuate the effect of TPEN (Fig 2A and 2C).
The effects of zinc availability on C. elegans lifespan require key transcription factors involved in longevity-determining pathways
To identify genes involved in the zinc-dependent effects on lifespan, we combined the effects of modulation of zinc levels with loss of function mutants of genes known to determine lifespan in C. elegans. We tested strains with mutations in the following genes: daf-16, a FOXO downstream effector molecule of insulin signaling pathway [45,46]; hsf-1, a heat shock factor-1 that binds heat shock response elements [47,48]; aak-2, an AMP-activated protein kinase that responds to the energy state of animal [49]; rsks-1, a putative ribosomal protein S6 kinase (S6K) involved in TOR pathway [50–53]; nhr-49, a nuclear hormone receptor (NHR) related to the mammalian HNF4 (hepatocyte nuclear factor 4) involved in fat metabolism [54]; skn-1, a putative transcription factor that promotes detoxification and stress resistance [55]; and clk-1, a mitochondrial protein demethoxyubiquinone (DMQ) hydroxylase necessary for ubiquinone biosynthesis [48,56]. These loss of function mutations resulted in altered baseline mean lifespans; compared to wildtype at 16.7±0.9 days, some strains had increased mean lifespan (rsks-1 at 17% and clk-1 at 17% increase), whereas other strains had decreased mean lifespan (daf-16 at 28%, hsf-1 at 20%, nhr-49 at 20%, aak-2 at 5% and skn-1 at 10% decrease) (Fig 3 and S1 Table).
The effect of zinc supplementation on lifespan was then evaluated in these loss of function strains (Fig 3 and S1 Table). The addition of 500μM zinc supplementation was found to shorten the control lifespan to 14.3±0.9 (14% decrease), consistent with previous findings. Compared to the control for each loss of function strain, zinc supplementation further decreased lifespan in strains with the loss of nhr-49 (12% decrease), rsks-1 (12% decrease), aak-2 (13% decrease), and clk-1 (14% decrease). However, zinc supplementation had minimal to no effect on the lifespan in strains with the loss of daf-16 (no change), hsf-1 (6% decrease), and skn-1 (2% decrease), suggesting that DAF-16, HSF-1, and SKN-1 may be required for the effects of zinc excess on lifespan. These finding also indicate that the effects of zinc excess on longevity are not simply a matter of toxicity, but are affecting lifespan through their impact on longevity signaling pathways.
The effect of zinc chelation with TPEN on lifespan was also evaluated in worms with the same loss of function strains (Fig 3 and S1 Table). The addition of 200μM TPEN was found to extend the wildtype lifespan to 22.9±1.1 (37% increase), consistent with previous findings. Compared to the control for each loss of function strain, TPEN treatment also increased lifespan in strains with loss of nhr-49 (39% increase), rsks-1 (27% increase), aak-2 (23% increase), clk-1 (33% increase), daf-16 (30% increase), hsf-1 (23% increase), and skn-1 (19% increase). The lifespan extending effects of zinc chelation on were less dependent on the tested longevity genes than the lifespan shortening effects of zinc excess.
Zinc availability regulates dauer formation in insulin/IGF-1 pathway mutant C. elegans
In C. elegans, inhibition of insulin/IGF-1 signaling results in DAF-16 nuclear localization, resulting in dauer formation [45,46,48,57]. The dauer phenotype is a developmentally-arrested alternative larval stage of the worm that is influenced by the insulin-like peptide [57]. Having observed that altered zinc levels modulate lifespan through the insulin/IGF-1 signaling pathway, we tested the downstream effects of zinc on longevity and dauer formation using zinc supplementation or chelation in two different daf-2 mutant worms populations. DAF-2 is an insulin/IGF receptor ortholog in C. elegans, and daf-2 mutants demonstrate higher levels of dauer formation [48,58]. Consistent with previous reports [58], the mean lifespan of two different daf-2 mutant alleles in control conditions was 32–35 days (110–135% increase), compared to ~15 days for control N2 strains, so we then examined the influence of altered levels of zinc. We observed that supplementation with 500μM zinc decreased lifespan (20–28%) relative whereas chelation with 100μM TPEN increased lifespan (33–58%), in daf-2 mutant controls (Fig 4A). We also observed that supplementation with 500μM zinc decreased dauer formation (30–34%) relative to daf-2 mutant controls, whereas zinc chelation with 100μM TPEN increased (20–32%) dauer formation (Fig 4B).
We then investigated whether the function of the DAF-16 transcription factor was altered by zinc imbalances. Upon inhibition of the insulin/IGF-1 pathway, DAF-16 translocates to the nucleus and activates specific target genes. We tested the localization of DAF-16::GFP in worms treated with zinc (500μM) or TPEN (200μM). In control and zinc-treated worms, DAF-16::GFP localization was mostly in a diffuse cytoplasmic pattern. In contrast, TPEN treatment promoted DAF-16 distinct punctate localization, suggesting nuclear translocation (Fig 4C and 4D). To further validate zinc-mediated suppression of DAF-16 nuclear entry, we heat-sensitized the DAF-16::GFP transgenic animals by exposing them to 34°C for 5 min, and examined for the localization of DAF-16::GFP in control worms and those with altered zinc levels. The percentage of worms with DAF-16 nuclear localization observed in control animals was 40±5%, compared to zinc supplemented animals 10±3%, and TPEN treated animals 95±3% (Fig 4E and 4F). The DAF-16::GFP localization studies support the idea that zinc modulates the activity of the transcription factor DAF-16 in vivo.
To further investigate whether the lifespan extended effects of TPEN, we used mutant worms or RNAi constructs such that the expression of both transcription factors, hsf-1 and skn-1 would be concomitantly reduced [59,60]. We examined the lifespan of double-mutant worms exposed to TPEN to reduce zinc levels in vivo. The double loss of function stains were significantly more effective at inhibiting the lifespan extending effects of TPEN than the single loss of function strains alone, resulting in a 15–20% reduction in mean lifespan (Fig 5A and 5B). Furthermore, we determined lifespan in worms from a daf-16 loss of function strain on bacteria expressing RNAi construct for hsf-1 or skn-1 in presence or absence of 200μM TPEN. Again the double loss of function stains were significantly more effective at inhibiting the lifespan extending effects of TPEN than the single loss of function strains alone, resulting in a 9–12% reduction in mean lifespan (Fig 5C and 5D). Together these experiments suggest that the transcription factors hsf-1, skn-1, and daf-16 are partially additive in the modulate lifespan under low zinc conditions.
Zinc levels modulate healthspan and protein aggregation in C. elegans
Analysis of worm strains treated with zinc (up to 500μM) or TPEN (up to 200μM) did not reveal any obvious changes in gross morphology (data not shown). We then examined the locomotor behavior of wildtype worms cultured with excess zinc or TPEN as a measure of the general health of the organisms. 5, 10, and 15-day-old worms were used to analyze the number of body bends per minute to measure age-related changes in locomotion. Supplementation with 500μM zinc did not significantly affect locomotion when worms were young but decreased the locomotion behavior when worms were older (S6 Fig). Treatment with 200μM TPEN did not significantly affect locomotion when worms were young but slowed the age-related decline in locomotion behavior. This same pattern in relation to zinc burden was also observed when locomotion behavior was measured after 4 hours of heat shock stress (S6 Fig). Both locomotion behavior and thermotolerance showed responsiveness to zinc availability in C. elegans.
Protein homeostasis plays a major role in longevity and healthspan in many organisms. Our group and others have previously shown that insoluble protein accumulates during normal aging in C. elegans [61–66]. Since a reduction in zinc increase lifespan and healthspan in worms, we hypothesized that reducing zinc burden in vivo might also slow age-dependent proteostasis. We examined the amount of insoluble proteins in animals grown on control or TPEN-treated NAMM plates and found that the animals exposed to TPEN had less insoluble protein in comparison to control animals (Fig 6A). The reduction of zinc in worms reduced the amount of insoluble protein aggregates formed during normal aging.
We also determined the role of hsf-1, skn-1, and daf-16 in relation to the effects of zinc reduction on age-dependent protein aggregation. To do this, we used the HE250 worm mutant which carries a mutation in the muscle protein UNC-52 (perlecan) that results in paralysis at 25°C [67]. Control worms treated with TPEN showed a significant reduction in paralysis compared to controls (Fig 6B and S7 Fig). However, RNAi knockdown of hsf-1, skn-1, or daf-16 partially blocked the effects of TPEN on protein aggregation-dependent paralysis compared to untreated controls. Thus, the effects of reduced zinc that modulate proteostasis may in part depend on expression of hsf-1, skn-1, and daf-16.
Discussion
Extensive studies have shown that adequate amount of different metals are required for healthy lifespan across a variety of species [68–72]. Zinc is one of the essential metals required for many biological processes in C. elegans. Under normal laboratory conditions, the dietary intake of zinc is provided by the feeding of bacteria. The worm is equipped to cope with fluctuations in zinc availability by regulating zinc uptake, sequestration, and elimination [34,35,42,73]. However, if aberrant levels of zinc persist, development and metabolism can be altered. Thus lifespan and healthspan could be affected by changes in zinc burden, but this not been fully characterized. We sought to determine the effects of zinc on C. elegans lifespan and healthspan, and how these effects are regulated by known longevity pathways.
Increasing zinc content in vivo using moderate levels of supplemental zinc did not result in overtly negative effects on the growth and development, yet there was a significant dose-dependent decrease in lifespan. Conversely, decreasing zinc content in vivo with a zinc-selective chelator resulted in significant increase in lifespan. This pattern of the detrimental effect of zinc excess and protective effect of zinc reduction was also consistent with phenotypes important in development and metabolism, including dauer formation, locomotion, thermotolerance, age-dependent protein aggregation, and age-dependent paralysis. It is unclear why C. elegans would maintain higher zinc levels under normal conditions when lower levels of zinc have longevity benefits, but there could be several reasons, including the possibility of antagonistic pleiotropy where higher zinc favors short-term benefits such as reproduction over long-term survival.
There are many known genes that play an important functional role in the regulation of lifespan in C. elegans. We tested some of these genes to determine if inactivation would block the effects of zinc excess or reduction. Our study shows that the effects of zinc imbalance on lifespan are modulated by daf-16, hsf-1, and skn-1. The genes hsf-1 and skn-1 are both part of stress defense pathways, which might be expected to be triggered when zinc levels become sub-optimum and metabolic processes become stressed. In particular, daf-16 played a significant role in modulating healthspan by altered zinc levels. DAF-16 is a master regulator of the insulin/IGF-1 signaling pathway, which has strong control over development and aging in the worm. Zinc is known to play an important role in the formation of insulin peptide in other organisms [74]. Furthermore, zinc has been reported to regulate insulin cell signaling and mammalian target of rapamycin (mTOR) signaling [75]. Further studies require for investigate the role of zinc and its relation of mTOR pathways in C. elegans.
Two additional findings were of note in our study. First, zinc excess was shown to affect lifespan and healthspan in worms only if treated at the beginning of adulthood. Increasing or decreasing zinc levels at day 5 of life did not affect the lifespan of the worm. The reasons for this are unclear, but could involve critical development processes that render the larval worm more sensitive to the changes in zinc, or the homeostatic effectors of zinc uptake and excretion in adults are more effective than in the larval development stage. This temporal requirement of zinc on lifespan and healthspan warrants further investigation. Secondly, reducing zinc levels were shown to slow the normal age-dependent increase in protein aggregation within the worm, which is a common feature of the disease of aging. The reasons for this are also unclear, but could involve direct effects, such as the removal of excess zinc ions from aggregated proteins. In numerous other disease models, zinc has been shown to modulate protein aggregation, including the promotion of beta amyloid aggregates in models of Alzheimer disease [76,77] and even urinary concretions in a D. melanogaster [78]. Moreover, the use of zinc-selective metal chelators has been shown to be efficacious in improving proteostasis and overall morbidity [79,80]. Alternatively, the reduction in zinc could also have indirect effects, such as disruption of redox states, stimulation of oxidant defense systems, or activation of pathways that degrade protein aggregates. Our observation that inactivation of specific genes can partially attenuate the affect of zinc chelation are suggestive of this last possibility. It is likely, however, that the effects of zinc reduction are a summation of multiple pro-longevity processes, which should be defined in detail in order to develop new approaches to modulate conserved longevity determining pathways.
Material and Method
C. elegans strains
C. elegans strains were maintained at 20°C on nematode growth media (NGM) agar plates seeded with E. coli strain OP50 [81]. For the lifespan experiments, NAMM agar plates seeded with E. coli strain OP50 were used [36]. The following animals were used in the study: wildtype, hsf-1(sy441), daf-16(86), aak-2(ok524), rsks-1(ok1255), nhr-49(ok2165), skn-1(eu31), clk-1(e2519), daf-2(e1370), daf-2(e1368), muEx108 ((pKL99-2) daf-16::GFP/daf16bKO + rol-6(su1006)), and HE250. All the strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). All assays utilized >/ = 300 worms per condition unless otherwise stated.
Bacterial strain
Bacterial strains K-12 and ZitB were grown in Luria-Bertani (LB) media, and subsequently grown on minimal media (50mL 1M NaCl, 7.5mL 5M NH4Cl, 2mL 0.5M CaCl2, 25 ml 1M phosphate buffer, 10mL 40% glucose, 1mL 1 mg/mL thiamine, 1mL 1M MgSO4, and QS to 1L with distilled water) at 37°C. Fully grown bacteria were spotted and cultured overnight at 37°C on minimal media plates (20g agar, 50mL 1M NaCl, 7.5mL 5M NH4Cl, 2mL 0.5M CaCl2, 1mL 5 mg/mL cholesterol, 25 ml 1M phosphate buffer, 10mL 40% glucose, 1mL 1 mg/mL thiamine, and 1mL 1M MgSO4, and QS to 1L with distilled water). These plates were used to perform lifespan assay.
Lifespan assay
Synchronized populations of L3 larval stage or adult worms were placed on NAMM agar plates supplemented with either ZnSO4 (500μM) or TPEN (200μM). The animals were transferred to fresh NGM plates every 2–3 days, and number of animals alive was scored every alternate day until death. Animals that failed to display touch-provoked movement were scored as dead. Animals that died from causes other than aging, such as sticking to the plate walls, internal hatching or bursting in the vulval region, were removed from the analysis. All lifespan experiments were performed at 20°C. Mean lifespan and number of worms used in each experiment are listed in S1 Table.
Worm development assay
Gravid adult hermaphrodites were treated with 1N NaOH and sodium hypochlorite (1:1) to release the eggs. The eggs were transferred to NAMM agar plates seeded with OP50 and supplemented with ZnSO4 (200–1000μM) or TPEN (50–200μM). Plates were then incubated at 20°C. After 3 days, images of control and treated animals were counted using microscopy.
Quantification of total zinc content
Synchronized population of L3 larval stage worms were placed on noble agar minimal media (NAMM) agar plates seeded with OP50 and supplemented with either ZnSO4 (500μM) or TPEN (200μM) followed by incubation at 20°C. After 48 hours, one-day adult animals were collected in M9 buffer (3g KH2PO4, 6g Na2HPO4, 5g NaCl, 1ml 1M MgSO4, and QS to 1L with distilled water). Worm pellets were created containing > 5000 worms each and washing 3 times with double distilled water. Tubes were incubated at 60°C to desiccate the worms and then weighted to obtain dry mass. The desiccated pellets of worms were dissolved by addition of 0.25 ml OmniTrace 70% HNO3 (EMD Chemicals) and incubated overnight at 60°C with 150–200 rpm orbital shaking. The acid lysates were then diluted to 5% HNO3 with OmniTrace water (EMD Chemicals), clarified by centrifugation (3000xg for 10 min), and introduced via a pneumatic concentric nebulizer using argon carrier gas into a Vista Pro inductively coupled plasma optimal emission spectrometry (ICP-OES; Varian Inc). The ICP-OES was calibrated using National Institute of Standards and Technology (NIST)-traceable elemental standards and validated using NIST-traceable 1577b bovine liver reference material. 34 elements including zinc were queried, with detection range between 0.005–50 parts per million and coefficient of variation (CV) for intra-assay and inter-assay precision typically ranging between 5%-10%. Cesium (50 ppm) was used for ionization suppression and yttrium (5 ppm) was used as an internal standard for all samples. All reagents and plasticware were certified or routinely tested for trace metal work. Elemental content data was summarized using native software (ICP Expert; Varian Inc) and normalized to dry weight of the worms.
Labile zinc content
The L3 larval stage worms were cultured as described above with supplementation of ZnSO4 (500μM) or TPEN (200μM). The worms were transferred on NAMM plate and incubated for one hour to minimize the signal due to auto-fluorescence. To measure zinc in vivo, worms were treated with FluoZin-3 (Molecular Probes/Invitrogen), which selectively binds to labile zinc ions and allows for detection of changes in the relative labile zinc concentration inside the worm [32, 43]. For quantification of FluoZin-3, images of live animals were taken in the linear range of exposure and quantified using ImageJ (NIH) software.
Dauer assay
Eggs were seeded on to NAMM agar plates supplemented with either ZnSO4 (500μM) or TPEN (100μM) seeded with OP50. Plates were incubated at 22°C for daf-2(e1370) and daf-2(e1368) worms. After 3–4 days, dauer and non-dauer worms are counted manually using a dissecting microscope. The dauer worm count was verified by treating the culture with 1% SDS for 45 min to dissolve away the non-dauer worms.
DAF-16::GFP localization shift assay
Synchronized population of L3 larval stage worms of transgenic line DAF-16::GFP were cultured on NAMM plate supplemented with either ZnSO4 (500μM) or TPEN (200μM) at 25°C. One day adult animals were used to monitor cytoplasmic or nuclear localization of DAF-16. The subcellular localization of DAF-16::GFP was obtained using fluorescence microscopy with an Olympus BX51 fluorescent microscope. To sensitize DAF-16::GFP worms, the plates were shifted to 34°C for 5 min, and monitored for nuclear localization of DAF-16::GFP. Data was expressed as the mean percentage of worms that show nuclear localization of DAF-16.
Mobility and heat stress assay
Worms were cultured on NAMM plate supplemented with either ZnSO4 (500μM) or TPEN (200μM) at 20°C. Treated worms were counted manually using a dissecting microscope for body bends for 10 seconds at the age of 5, 10, 15 days of adult hood and then expressed as the mean number of body bends per minute. For heat stress assay, similar age group worms were shifted to 34°C for 4 hours and then allowed to recover for 10 hours at 20°C. After recovery time, the number of live worms was counted. Three to four experimental replicates were carried out with three to four plate replicates per trial. Data was expressed as the mean number of surviving worms.
RNAi analysis
RNA interference procedures were performed as previously described [82]. Worms were grown at 20°C and synchronized eggs were used to obtain a synchronized L3 larval stage population. L3 worms were moved to RNAi plates (NAMM containing 100mg/ml ampicillin, 20 mg/ml tetracycline, 1 mM IPTG) spotted with bacteria expressing double-stranded RNAi. The second generation animals obtained from RNAi of hsf-1 and skn-1 were exposed to hsf-1(RNAi) and skn-1(RNAi) with and without TPEN (200μM). The hsf-1(RNAi) and skn-1(RNAi) clones were obtained from the Ahringer library and confirmed by sequencing [83].
Analysis of insoluble protein
Approximately 5000 synchronized population of L4 larval stage TJ1060 [spe-9(hc88)I; fer-15(b26)II][84] worms were plated on NAMM plate supplemented with TPEN (200μM) and spotted with E. coli (NA22) at 25°C (restrictive temperature). This strain does not produce fertile eggs at 25°C degree so aggregation studies will be limited to the parental generation. Worm (120-150mg total protein) were collected in M9-buffer from several plates at 6 days adulthood. Worms were washed several times with S-basal (5.85 g NaCl, 1 g K2HPO4, 6 g KH2PO4, 1 ml cholesterol (5 mg/mL in ethanol), and QS to 1 L with distilled water) and re-suspended in aqueous lysis buffer (20 mM Tris, 100 mM NaCl, 1 mM MgCl2, pH 7.4) with protease inhibitor cocktail (COMPLETE, Roche Diagnostics, Mannheim, Germany). The samples were sonicated (for 3 minute for 4W power, 30 cycles) on ice and then centrifuged at 3000xg to remove carcasses. All samples were normalized for total protein concentration as assessed by BCA assay (Thermo Fisher Scientific, Rockford, IL, USA) for further processing. Samples were centrifuged at 16,000xg and washed three times to extract the water-soluble protein fraction. The pellet was then re-suspended and washed three times in the same buffer containing 1% SDS to retain the detergent-soluble protein fraction. Finally, the insoluble fraction was then treated for 1 h with 70% formic acid with vigorous shaking at room temperature. The acidic fractions were concentrated in a Speed-Vac at 25°C. The samples were dissolved and SDS-PAGE was performed using 10% Bis—Tris gel NuPAGE system.
Paralysis analysis
HE250 worm mutants which carry a mutation in the muscle protein UNC-52 (perlecan) were maintained at 16°C. Synchronized population of L3 stage HE250 worms were transferred on to NAMM media plate treated with TPEN. Plates were incubated at 16°C for 12–16 hours and then shifted to 25°C for 48 hours. After incubation for 48 hours at 25°C animals were scored for paralysis by checking for touch-provoked movement and counted manually using a dissecting microscope.
Statistics
Survival curves were plotted and statistical analyses were performed using the Prism software (Graphpad Software, Inc., San Diego, CA, USA).
Supporting Information
Acknowledgments
We thank the members of the Kapahi and Lithgow labs for helpful advice and critical discussion. We thank Tai Holland from the CHORI Elemental Analysis Facility for technical assistance. This work was supported in part by an American Foundation for Aging Research Mid-Career Award and NIH/NIA Grants AG045835 and AG038688 (PK). Also, we thank to DBT-PU-IPLS Programme, Govt. of India and DST for young scientist award (SB/YS/LS-166/2014) for financial support.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was supported in part by an American Foundation for Aging Research Mid-Career Award and NIH/NIA Grants AG045835 and AG038688 (PK). Also, the authors thank DBT-PU-IPLS Programme, Govt. of India and DST for young scientist award (SB/YS/LS-166/2014) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Kamata H, Hirata H (1999) Redox regulation of cellular signalling. Cell Signal 11: 1–14. [DOI] [PubMed] [Google Scholar]
- 2.Maret W (2000) The function of zinc metallothionein: a link between cellular zinc and redox state. J Nutr 130: 1455S–1458S. [DOI] [PubMed] [Google Scholar]
- 3.Murakami M, Hirano T (2008) Intracellular zinc homeostasis and zinc signaling. Cancer Sci 99: 1515–1522. 10.1111/j.1349-7006.2008.00854.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Vallee BL, Auld DS (1990) Zinc coordination, function, and structure of zinc enzymes and other proteins. Biochemistry 29: 5647–5659. [DOI] [PubMed] [Google Scholar]
- 5.Vallee BL, Auld DS (1993) Cocatalytic zinc motifs in enzyme catalysis. Proc Natl Acad Sci U S A 90: 2715–2718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yamasaki S, Sakata-Sogawa K, Hasegawa A, Suzuki T, Kabu K, Sato E, et al. (2007) Zinc is a novel intracellular second messenger. J Cell Biol 177: 637–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bedwal RS, Bahuguna A (1994) Zinc, copper and selenium in reproduction. Experientia 50: 626–640. [DOI] [PubMed] [Google Scholar]
- 8.Favier AE (1992) The role of zinc in reproduction. Hormonal mechanisms. Biol Trace Elem Res 32: 363–382. [DOI] [PubMed] [Google Scholar]
- 9.Fraker PJ, King LE (2004) Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr 24: 277–298. [DOI] [PubMed] [Google Scholar]
- 10.Frederickson CJ, Suh SW, Silva D, Thompson RB (2000) Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130: 1471S–1483S. [DOI] [PubMed] [Google Scholar]
- 11.Nishi Y (1996) Zinc and growth. J Am Coll Nutr 15: 340–344. [DOI] [PubMed] [Google Scholar]
- 12.Rink L, Gabriel P (2000) Zinc and the immune system. Proc Nutr Soc 59: 541–552. [DOI] [PubMed] [Google Scholar]
- 13.Rossi L, Migliaccio S, Corsi A, Marzia M, Bianco P, Teti A, et al. (2001) Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. J Nutr 131: 1142–1146. [DOI] [PubMed] [Google Scholar]
- 14.Andrews M, Gallagher-Allred C (1999) The role of zinc in wound healing. Adv Wound Care 12: 137–138. [PubMed] [Google Scholar]
- 15.Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Agren MS (2007) Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 15: 2–16. [DOI] [PubMed] [Google Scholar]
- 16.Lin LC, Que J, Lin LK, Lin FC (2006) Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study. Int J Radiat Oncol Biol Phys 65: 745–750. [DOI] [PubMed] [Google Scholar]
- 17.McClain C, Soutor C, Zieve L (1980) Zinc deficiency: a complication of Crohn's disease. Gastroenterology 78: 272–279. [PubMed] [Google Scholar]
- 18.Myung SJ, Yang SK, Jung HY, Jung SA, Kang GH, Ha HK, et al. (1998) Zinc deficiency manifested by dermatitis and visual dysfunction in a patient with Crohn's disease. J Gastroenterol 33: 876–879. [DOI] [PubMed] [Google Scholar]
- 19.Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ (1996) Zinc status and serum testosterone levels of healthy adults. Nutrition 12: 344–348. [DOI] [PubMed] [Google Scholar]
- 20.Fosmire GJ (1990) Zinc toxicity. Am J Clin Nutr 51: 225–227. [DOI] [PubMed] [Google Scholar]
- 21.Palmiter RD (2004) Protection against zinc toxicity by metallothionein and zinc transporter 1. Proc Natl Acad Sci U S A 101: 4918–4923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci 6: 449–462. [DOI] [PubMed] [Google Scholar]
- 23.Lee SJ, Koh JY (2010) Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes. Mol Brain 3: 30 10.1186/1756-6606-3-30 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Takeda A (2000) Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 34: 137–148. [DOI] [PubMed] [Google Scholar]
- 25.Krebs NF (2000) Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 130: 1374S–1377S. [DOI] [PubMed] [Google Scholar]
- 26.King JC, Shames DM, Woodhouse LR (2000) Zinc homeostasis in humans. J Nutr 130: 1360S–1366S. [DOI] [PubMed] [Google Scholar]
- 27.Jacob C, Maret W, Vallee BL (1998) Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc Natl Acad Sci U S A 95: 3489–3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Chen Y, Maret W (2001) Catalytic selenols couple the redox cycles of metallothionein and glutathione. Eur J Biochem 268: 3346–3353. [DOI] [PubMed] [Google Scholar]
- 29.Colvin RA, Holmes WR, Fontaine CP, Maret W (2010) Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2: 306–317. 10.1039/b926662c [DOI] [PubMed] [Google Scholar]
- 30.Eide DJ (2006) Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763: 711–722. [DOI] [PubMed] [Google Scholar]
- 31.Gaither LA, Eide DJ (2001) Eukaryotic zinc transporters and their regulation. Biometals 14: 251–270. [DOI] [PubMed] [Google Scholar]
- 32.Roh HC, Collier S, Guthrie J, Robertson JD, Kornfeld K (2012) Lysosome-related organelles in intestinal cells are a zinc storage site in C. elegans. Cell Metab 15: 88–99. 10.1016/j.cmet.2011.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zeitoun-Ghandour S, Charnock JM, Hodson ME, Leszczyszyn OI, Blindauer CA, Stürzenbaum SR (2010) The two Caenorhabditis elegans metallothioneins (CeMT-1 and CeMT-2) discriminate between essential zinc and toxic cadmium. FEBS J 277: 2531–2542. 10.1111/j.1742-4658.2010.07667.x [DOI] [PubMed] [Google Scholar]
- 34.Wang D, Shen L, Wang Y (2007) The phenotypic and behavioral defects can be transferred from zinc-exposed nematodes to their progeny. Environ Toxicol Pharmacol 24: 223–230. 10.1016/j.etap.2007.05.009 [DOI] [PubMed] [Google Scholar]
- 35.Shen L, Xiao J, Ye H, Wang D (2009) Toxicity evaluation in nematode Caenorhabditis elegans after chronic metal exposure. Environ Toxicol Pharmacol 28: 125–132. 10.1016/j.etap.2009.03.009 [DOI] [PubMed] [Google Scholar]
- 36.Bruinsma JJ, Jirakulaporn T, Muslin AJ, Kornfeld K (2002) Zinc ions and cation diffusion facilitator proteins regulate Ras-mediated signaling. Dev Cell 2: 567–578. [DOI] [PubMed] [Google Scholar]
- 37.Jakubowski J, Kornfeld K (1999) A local, high-density, single-nucleotide polymorphism map used to clone Caenorhabditis elegans cdf-1. Genetics 153: 743–752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Davis DE, Roh HC, Deshmukh K, Bruinsma JJ, Schneider DL, Robertson JD, et al. (2009) The cation diffusion facilitator gene cdf-2 mediates zinc metabolism in Caenorhabditis elegans. Genetics 182: 1015–1033. 10.1534/genetics.109.103614 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Bruinsma JJ, Schneider DL, Davis DE, Kornfeld K (2008) Identification of mutations in Caenorhabditis elegans that cause resistance to high levels of dietary zinc and analysis using a genomewide map of single nucleotide polymorphisms scored by pyrosequencing. Genetics 179: 811–828. 10.1534/genetics.107.084384 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Freedman JH, Slice LW, Dixon D, Fire A, Rubin CS (1993) The novel metallothionein genes of Caenorhabditis elegans. Structural organization and inducible, cell-specific expression. J Biol Chem 268: 2554–2564. [PubMed] [Google Scholar]
- 41.Yoder JH, Chong H, Guan KL, Han M (2004) Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase. EMBO J 23: 111–119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Bofill R, Orihuela R, Romagosa M, Domenech J, Atrian S, Capdevila M (2009) Caenorhabditis elegans metallothionein isoform specificity—metal binding abilities and the role of histidine in CeMT1 and CeMT2. FEBS J 276: 7040–7056. 10.1111/j.1742-4658.2009.07417.x [DOI] [PubMed] [Google Scholar]
- 43.Zhao J, Bertoglio BA, Gee KR, Kay AR (2008) The zinc indicator FluoZin-3 is not perturbed significantly by physiological levels of calcium or magnesium. Cell Calcium 44: 422–426. 10.1016/j.ceca.2008.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Grass G, Fan B, Rosen BP, Franke S, Nies DH, Rensing C (2001) ZitB (YbgR), a member of the cation diffusion facilitator family, is an additional zinc transporter in Escherichia coli. J Bacteriol 183: 4664–4667. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Lin K, Dorman JB, Rodan A, Kenyon C (1997) daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319–1322. [DOI] [PubMed] [Google Scholar]
- 46.Lee SS, Kennedy S, Tolonen AC, Ruvkun G (2003) DAF-16 target genes that control C. elegans life-span and metabolism. Science 300: 644–647. [DOI] [PubMed] [Google Scholar]
- 47.Garigan D, Hsu AL, Fraser AG, Kamath RS, Ahringer J, Kenyon C (2002) Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics 161: 1101–1112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, et al. (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424: 277–283. [DOI] [PubMed] [Google Scholar]
- 49.Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R (2004) The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18: 3004–3009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Pan KZ, Palter JE, Rogers AN, Olsen A, Chen D, Lithgow GJ, et al. (2007) Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 6: 111–119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kapahi P, Zid B (2004) TOR pathway: linking nutrient sensing to life span. Sci Aging Knowledge Environ 2004: PE34 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Chen D, Thomas EL, Kapahi P (2009) HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS Genet 5: e1000486 10.1371/journal.pgen.1000486 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Chen D, Li PW, Goldstein BA, Cai W, Thomas EL, Chen F, et al. (2013) Germline signaling mediates the synergistically prolonged longevity produced by double mutations in daf-2 and rsks-1 in C. elegans. Cell Rep 5: 1600–1610. 10.1016/j.celrep.2013.11.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Brock TJ, Browse J, Watts JL (2006) Genetic regulation of unsaturated fatty acid composition in C. elegans. PLoS Genet 2: e108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Tullet JM, Hertweck M, An JH, Baker J, Hwang JY, Liu S, et al. (2008) Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132: 1025–1038. 10.1016/j.cell.2008.01.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Felkai S, Ewbank JJ, Lemieux J, Labbe JC, Brown GG, Hekimi S (1999) CLK-1 controls respiration, behavior and aging in the nematode Caenorhabditis elegans. EMBO J 18: 1783–1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Gottlieb S, Ruvkun G (1994) daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics 137: 107–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942–946. [DOI] [PubMed] [Google Scholar]
- 59.Kamath RS, Ahringer J (2003) Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30: 313–321. [DOI] [PubMed] [Google Scholar]
- 60.Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J (2000) Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408: 325–330. [DOI] [PubMed] [Google Scholar]
- 61.Koga H, Kaushik S, Cuervo AM (2011) Protein homeostasis and aging: The importance of exquisite quality control. Ageing Res Rev 10: 205–215. 10.1016/j.arr.2010.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Douglas PM, Dillin A (2010) Protein homeostasis and aging in neurodegeneration. J Cell Biol 190: 719–729. 10.1083/jcb.201005144 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kikis EA, Gidalevitz T, Morimoto RI (2010) Protein homeostasis in models of aging and age-related conformational disease. Adv Exp Med Biol 694: 138–159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.David DC, Ollikainen N, Trinidad JC, Cary MP, Burlingame AL, Kenyon C (2010) Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol 8: e1000450 10.1371/journal.pbio.1000450 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Sonani RR, Singh NK, Awasthi A, Prasad B, Kumar J, Madamwar D (2014) Phycoerythrin extends life span and health span of Caenorhabditis elegans. Age (Dordr) 36: 9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Kumar J, Park KC, Awasthi A, Prasad B (2015) Silymarin extends lifespan and reduces proteotoxicity in C. elegans Alzheimer's model. CNS Neurol Disord Drug Targets 14: 295–302. [DOI] [PubMed] [Google Scholar]
- 67.Rogalski TM, Gilchrist EJ, Mullen GP, Moerman DG (1995) Mutations in the unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis elegans are located in alternatively spliced exons. Genetics 139: 159–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Leung MC, Williams PL, Benedetto A, Au C, Helmcke KJ, Aschner M, et al. (2008) Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 106: 5–28. 10.1093/toxsci/kfn121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Wang D, Xing X (2008) Assessment of locomotion behavioral defects induced by acute toxicity from heavy metal exposure in nematode Caenorhabditis elegans. J Environ Sci (China) 20: 1132–1137. [DOI] [PubMed] [Google Scholar]
- 70.Fraga CG (2005) Relevance, essentiality and toxicity of trace elements in human health. Mol Aspects Med 26: 235–244. [DOI] [PubMed] [Google Scholar]
- 71.Underwood EJ (1981) Trace metals in human and animal health. J Hum Nutr 35: 37–48. [DOI] [PubMed] [Google Scholar]
- 72.Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress, and human health. Mol Aspects Med 26: 268–298. [DOI] [PubMed] [Google Scholar]
- 73.Murphy JT, Bruinsma JJ, Schneider DL, Collier S, Guthrie J, Chinwalla A, et al. (2011) Histidine protects against zinc and nickel toxicity in Caenorhabditis elegans. PLoS Genet 7: e1002013 10.1371/journal.pgen.1002013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Myers SA, Nield A, Myers M (2012) Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus. J Nutr Metab 2012: 173712 10.1155/2012/173712 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Lynch CJ, Patson BJ, Goodman SA, Trapolsi D, Kimball SR (2001) Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR. Am J Physiol Endocrinol Metab 281: E25–34. [DOI] [PubMed] [Google Scholar]
- 76.Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, et al. (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265: 1464–1467. [DOI] [PubMed] [Google Scholar]
- 77.Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI (2000) Alzheimer's disease, beta-amyloid protein and zinc. J Nutr 130: 1488S–1492S. [DOI] [PubMed] [Google Scholar]
- 78.Chi T, Kim MS, Lang S, Bose N, Kahn A, Flechner L, et al. (2015) A Drosophila model identifies a critical role for zinc in mineralization for kidney stone disease. PLoS One 10: e0124150 10.1371/journal.pone.0124150 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Adlard PA, Parncutt J, Lal V, James S, Hare D, Doble P, et al. (2014) Metal chaperones prevent zinc-mediated cognitive decline. Neurobiol Dis. [DOI] [PubMed] [Google Scholar]
- 80.Sensi SL, Paoletti P, Bush AI, Sekler I (2009) Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 10: 780–791. 10.1038/nrn2734 [DOI] [PubMed] [Google Scholar]
- 81.Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Olsen A, Vantipalli MC, Lithgow GJ (2006) Using Caenorhabditis elegans as a model for aging and age-related diseases. Ann N Y Acad Sci 1067: 120–128. [DOI] [PubMed] [Google Scholar]
- 83.Qu W, Ren C, Li Y, Shi J, Zhang J, Wang X, et al. (2011) Reliability analysis of the Ahringer Caenorhabditis elegans RNAi feeding library: a guide for genome-wide screens. BMC Genomics 12: 170 10.1186/1471-2164-12-170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Fabian TJ, Johnson TE (1995) Identification genes that are differentially expressed during aging in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci 50: B245–253. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.